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severe than with a standard graft after conventional vascu- 
lar surgery. 2 Therefore, guidelines have to be established 
concerning the duration and necessity of long-term antibi- 
otic treatment and prophylaxis after endovascular therapy.3 
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Regarding " Impact of  arterial surgery and balloon 
angioplasty on amputation: A population-based study 
of  1155 procedures between 1973 and 1992" 
To the Editors: 
I read with great interest the paper "Impact of arterial 
surgery and balloon angioplasty on amputation" by Hallett 
et al., published in the January issue of the Journal of 
Vascular Surgery (1997;25:29 - 38 ). The conclusion of the 
study: "..:increased vascular surgery and balloon angio- 
plasty rates have played significant roles in the reduction of 
major amputations..." is indeed an important one. The 
shortcoming of the paper is, however, that it "lumps to- 
gether" in the group "major amputations" patients who 
had either below-lmee or above-knee amputations. It is 
common knowledge that lthough most patients with be- 
low-knee amputations may be rehabilitated to a well, func- 
tional level, those who require above-knee amputations 
remain severely handicapped. In this latter espect, recon- 
structive vascular surgery may play a somewhat ambiguous 
role. In our retrospective r view of 300 consecutive pa- 
tients who underwent major lower limb amputations atthe 
Carolinas Medical Center, 1 we found that in patients who 
failed vascular surgery the above-knee amputation rate was 
twice than in those in whom amputation was performed as 
a primary operation. We conclude that reconstructive as- 
cular surgery, although it is indeed a most effective treat- 
ment to prevent the need for amputation per se, if it fails, 
however, is associated with an increased incidence of crip- 
pling above-knee amputations. Therefore, it should be 
used judiciously, especially in cases where the chances of 
failure is high. 
Francis Robicsek, MD, PhD 
Department ofThoracic, Cardiac, nd Peripheral Vascular 
Surgery 
Sanger Clinic 
1001 Blythe Blvd., Suite 300 
Charlotte, N.C. 28203 
REFERENCE 
1. Robicsek F. Vascular surgery: possible adverse effect on extent 
of subsequent lower limb amputation. South Med J 1992;85: 
1190-2. 
24/41/82833 
Reply 
To the Editors: 
Dr. Robicsek has emphasized the importance of 
achieving a below-knee amputation when lower extremity 
revascularization procedures fail. Our original analysis of 
more than 1000 lower extremity procedures was searching 
for epidemiologic changes in all amputations in a defined 
community. We did not initially set out to ascertain the 
anatomic or surgical nuances that affected whether the 
major amputation was belowq~nee or above-knee when 
revascularization could not be achieved. Dr. Robicsek 
raises the value of this more-detailed analysis, and we 
appreciate he stimulus to return to our defined population 
and seek the answer to his cogent inquiry. As our article 
indicated, many patients in our community underwent 
primary amputation without an attempt at revasculariza- 
tion because of advanced ischemia or infection at initial 
presentation. Whenever possible, a below-knee operation 
was attempted. 
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